Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 14, Issue 1, 2015, Pages 63-69

  Roux, Anne Laure ^a,b   Catherinot, Emilie ^a,d   Soismier, Nathalie ^a,c   Heym, Beate ^a,c   Bellis, Gil ^e   Lemonnier, Lydie ^f   Chiron, Raphaël ^g   Fauroux, Brigitte ^h   Le Bourgeois, Muriel ⁱ   Munck, Anne ^j   Pin, Isabelle ^k   Sermet, Isabelle ⁱ   Gutierrez, Cristina ^l   Véziris, Nicolas ^m,n   Jarlier, Vincent ^m,n   Cambau, Emmanuelle ^m,o   Herrmann, Jean Louis ^a,b   Guillemot, Didier ^a,l,p   Gaillard, Jean Louis ^a,b,c  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d FOCH HOSPITAL   (France)

^e INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^f Association Vaincre la Mucoviscidose   (France)

^g HÔPITAL ARNAUD DE VILLENEUVE   (France)

^h ARMAND TROUSSEAU HOSPITAL   (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j HÔPITAL ROBERT DEBRÉ   (France)

^k GRENOBLE UNIVERSITY HOSPITAL   (France)

^l INSTITUT PASTEUR   (France)

^m AP HP HÔpital Pitié Salpêtrière Centre National de Référence des Mycobactéries de la Résistance des Mycobactéries aux Antituberculeux Bacteriologie Hygiene   (France)

ⁿ SORBONNE UNIVERSITÉ   (France)

^o ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^p INSERM U657   (France)

more..

Author keywords

Cystic fibrosis; Malnutrition; Mycobacterium abscessus complex; Nontuberculous mycobacteria

Indexed keywords

AMIKACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; IMIPENEM; LINEZOLID; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; BODY MASS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG INFECTION; MALE; MALNUTRITION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM MASSILIENSE; NONHUMAN; TREATMENT RESPONSE; AGE DISTRIBUTION; ATYPICAL MYCOBACTERIUM; CHI SQUARE DISTRIBUTION; CLASSIFICATION; COHORT ANALYSIS; COMORBIDITY; DRUG EFFECTS; FRANCE; ISOLATION AND PURIFICATION; LUNG TRANSPLANTATION; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME;

AGE DISTRIBUTION; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; FRANCE; HUMANS; LUNG TRANSPLANTATION; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84918818876     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.07.004     Document Type: Article

References (38)

1. Leao S.C., Tortoli E., Euzeby J.P., Garcia M.J. Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus. Int J Syst Evol Microbiol 2011, 61:2311-2313.
2. Adekambi T., Reynaud-Gaubert M., Greub G., Gevaudan M.J., La Scola B., Raoult D., et al. Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol 2004, 42:5493-5501.
3. Jonsson B.E., Gilljam M., Lindblad A., Ridell M., Wold A.E., Welinder-Olsson C. Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis. J Clin Microbiol 2007, 45:1497-1504.
4. Esther C.R., Henry M.M., Molina P.L., Leigh M.W. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 2005, 40:39-44.
5. Olivier K.N., Weber D.J., Wallace R.J., Faiz A.R., Lee J.H., Zhang Y., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:828-834.
6. Roux A.L., Catherinot E., Rippoll F., Soismier N., Macheras E., Ravilly S., et al. Multicenter French prevalence study of non tuberculous mycobacteria in cystic fibrosis. J Clin Microbiol 2009, 47:4124-4128.
7. Chalermskulrat W., Sood N., Neuringer I.P., Hecker T.M., Chang L., Rivera M.P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006, 61:507-513.
8. Pierre-Audigier C., Ferroni A., Sermet-Gaudelus I., Le Bourgeois M., Offredo C., Vu-Thien H., et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005, 43:3467-3470.
9. Brown-Elliott B.A., Wallace R.J. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002, 15:716-746.
10. Sanguinetti M., Ardito F., Fiscarelli E., La Sorda M., D'Argenio P., Ricciotti G., et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001, 39:816-819.
11. Griffith D.E., Aksamit T.R. Therapy of refractory nontuberculous mycobacterial lung disease. Curr Opin Infect Dis 2012, 25:218-227.
12. Nessar R., Cambau E., Reyrat J.M., Murray A., Gicquel B. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 2012, 67:810-818.
13. Bastian S., Veziris N., Roux A.L., Brossier F., Gaillard J.L., Jarlier V., et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother 2011, 55:775-781.
14. Nash K.A., Brown-Elliott B.A., Wallace R.J. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009, 53:1367-1376.
15. Aitken M.L., Limaye A., Pottinger P., Whimbey E., Goss C.H., Tonelli M.R., et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med 2012, 185:231-232.
16. Zelazny A.M., Root J.M., Shea Y.R., Colombo R.E., Shamputa I.C., Stock F., et al. Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J Clin Microbiol 2009, 47:1985-1995.
17. van Ingen J., de Zwaan R., Dekhuijzen R.P., Boeree M.J., van Soolingen D. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. J Infect 2009, 59:324-331.
18. Harada T., Akiyama Y., Kurashima A., Nagai H., Tsuyuguchi K., Fujii T., et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol 2012, 50:3556-3561.
19. Koh W.J., Jeon K., Lee N.Y., Kim B.J., Kook Y.H., Lee S.H., et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011, 183:405-410.
20. Chopra S., Matsuyama K., Hutson C., Madrid P. Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. J Antimicrob Chemother 2011, 66:1533-1536.
21. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
22. Adekambi T., Colson P., Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol 2003, 41:5699-5708.
23. Ringuet H., Akoua-Koffi C., Honore S., Varnerot A., Vincent V., Berche P., et al. hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol 1999, 37:852-857.
24. Macheras E., Roux A.L., Bastian S., Leão S.C., Palaci M., Sivadon-Tardy V., et al. Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J Clin Microbiol 2011, 49:491-499.
25. Kartalija M., Ovrutsky A.R., Bryan C.L., Pott G.B., Fantuzzi G., Thomas J., et al. Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med 2013, 187:197-205.
26. Chan E.D., Iseman M.D. Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gend Med 2010, 7:5-18.
27. Tasaka S., Hasegawa N., Nishimura T., Yamasawa W., Kamata H., Shinoda H., et al. Elevated serum adiponectin level in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Respiration 2010, 79:383-387.
28. Brown G.R. Anorexia nervosa complicated by Mycobacterium xenopi pulmonary infection. J Nerv Ment Dis 1987, 175:629-632.
29. Cosson M.A., Bertrand J.B., Martin C., Veziris N., Picard C., Goulvestre C., et al. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient. J Med Microbiol 2012, 61:1617-1620.
30. Nova E., Samartin Gomez S., Morandé G., Marcos A. The adaptive response of the immune system to the particular malnutrition of eating disorders. Eur J Clin Nutr 2002, 56(Suppl. 3):S34-S37.
31. Shin S.J., Choi G.E., Cho S.N., Woo S.Y., Jeong B.H., Jeon K., et al. Mycobacterial genotypes are associated with clinical manifestation and progression of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense. Clin Infect Dis 2013, 57:32-39.
32. Lai H.C., Kosorok M.R., Sondel S.A., Chen S.T., FitzSimmons S.C., Green C.G., et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 1998, 132:478-485.
33. Steinkamp G., Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002, 57:596-601.
34. Dodge J.A., Lewis P.A., Stanton M., Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007, 29:522-526.
35. U.S.Cystic Fibrosis Foundation The Cystic Fibrosis Patient Registry: Annual data report 2011, Available from: www.cff.org.
36. Kim H.Y., Kim B.J., Kook Y., Yun Y.J., Shin J.H., Kim B.J., et al. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol Immunol 2010, 54:347-353.
37. Gilljam M., Schersten H., Silverborn M., Jönsson B., Ericsson Hollsing A. Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. J Cyst Fibros 2010, 9:272-276.
38. Macheras E., Roux A.L., Ripoll F., Sivadon-Tardy V., Gutierrez C., Gaillard J.L., et al. Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J Clin Microbiol 2009, 47:2596-2600.